This study was designed to assess the potential subchronic inhalation toxicity of caprolactam when administered as a 3-fim aerosol from an aqueous solution to Sprague-Dawley CD rats (10/sex/group) via whole-body exposure. The study was enhanced with the inclusion of motor activity measurements and a functional observational battery to assess the neurotoxic potential of caprolactam. The rats were exposed at least 65 times over a 13-week period for 6 h per day, 5 days per week, to target concentrations (3 /xm, mass median aerodynamic diameter) of 0, 25, 75, and 250 milligrams per cubic meter (mg/m 3 ). An additional 10 animals/sex/group were similarly exposed and then held for a 4-week recovery period. Exposure levels were determined gravimetrically six times daily; one daily sample was analyzed by high-pressure liquid chromatography. No deaths were observed in the study during the exposure or recovery periods. Treatment-related responses such as labored breathing and nasal discharge were seen during many of the exposures. Similar responses as well as moist rales were seen during the nonexposure periods during the 13 weeks of exposure. However, these responses abated during the 4-week recovery period. There were no clearly treatment-related responses observed with ophthalmoscopic examinations, body weight measurements, food consumption measurements, neurobehavioral evaluations, clinical pathology evaluations, organ weight measurements, or macroscopic pathology examinations. Microscopic findings that were considered related to exposure to the test material were seen in the nasoturbinal tissues (hypertrophy/hyperplasia of goblet cells in the respiratory mucosa and intracytoplasmic eosinophilic material in epithelial cells of the olfactory mucosa) of the two higher-exposure group animals and in the laryngeal tissues (squamous/squamoid meta- 2 To whom all correspondence should be addressed.
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Caprolactam (2-oxohexamethylenimine, CgHnNO, CAS No. 105-60-2) is a large-volume chemical used primarily as the monomer in the production of Nylon 6 fibers, films, and resins. A large toxicological database exists for caprolactam. Its extremely low vapor pressure (0.0021 mm Hg at 25°C, equivalent to a saturated vapor concentration of about 13 mg/m 3 or ~3 ppm) renders the conduct of meaningful vapor inhalation toxicity studies infeasible. Because of this inherent physical property, toxicity studies on caprolactam have historically been conducted in laboratory animals primarily via the oral route of administration.
A few studies have dealt with inhalation exposure of caprolactam aerosols to laboratory animals. Exposure of guinea pigs to caprolactam at 51 mg/m 3 for 5 to 8 h per day for 26 or 30 days did not result in any pathological effects or evidence of abnormal mobility. However, slight evidence of irritation of the nasal mucosa was observed (Hohensee, 1951) . No adverse effects, except for occasional coughing, were noted in a study in which three guinea pigs were exposed for 7 h daily for 7 days to concentra-tions of caprolactam varying on different days from 118 to 261 mg/m 3 (Goldblatt et al, 1954) . A 2-h LC50 value of 450 mg/m 3 was reported for albino mice (Lomonova, 1966) . No visible signs of toxicity were noted after 2 h of exposure to caprolactam at a concentration of 230 mg/m 3 . When the exposure level was increased, some animals (3 of 10 exposed to 440 mg/m 3 and 6 of 8 exposed to 560 to 750 mg/m 3 ) displayed "spasm attacks." No apparent toxicity was observed in albino rats exposed for 2 h to 650 to 700 mg/m 3 , noted as the highest concentration attainable. Lomonova concluded that caprolactam increases the excitability of the central nervous system. In a more recent acute inhalation toxicity study, conducted in accordance with GLPs (Good Laboratory Practices), the 4-h LC50 value for rats was determined to be 8160 mg/m 3 (Klimisch, 1985) . No evidence of immediate pulmonary hypersensitivity, respiratory irritation, coughing, airway constriction, or sensory irritation was found in a study in which guinea pigs were exposed to aqueous aerosol concentrations of caprolactam up to 26.3 mg/m 3 for 30 min a day for 5 days, followed 14, 21, 28, and 35 days later by 30-min exposures (Alarie and Stock, 1990) .
A number of human occupational studies have been conducted (Ferguson and Wheeler, 1973; Kelman, 1986; Billmaier, 1992; Patel, 1990 ). Ferguson and Wheeler observed nasal and throat irritation in workers exposed to caprolactam at a concentration of 46 mg/m 3 (10 ppm), but no distress at concentrations ranging up to about 32 mg/m 3 (7 ppm). These investigators characterized the airborne caprolactam to which their subjects were exposed as vapor. Recent experimental determinations of caprolactam's vapor pressure would argue that most of the exposures in the Ferguson and Wheeler study were likely to be aerosol and vapor, rather than vapor alone, because the reported concentrations were higher than the saturated vapor concentration calculated for ambient temperature. Results obtained from the Ferguson and Wheeler study formed the basis for the American Conference of Governmental Industrial Hygienists' (ACGIH) time-weighted-average threshold limit value (TLV-TWA) of 5 ppm, or 23 mg/m 3 , for caprolactam vapor. This TLV was established in 1966 and no systemic toxicity has been reported for more than 30 years.
Kelman, on studying a group of eight workers who had been chronically exposed to mean atmospheric caprolactam levels of about 70 mg/m 3 (approximately 70 times the TLV of 1 mg/m 3 for caprolactam dust) for an average of 4.8 years (range, 9 months to 13 years), reported that several workers complained of some degree of eye, nose, or throat irritation and all but one experienced peeling of the skin of the hands and sometimes of the feet. There was, however, no evidence of systemic toxicity or pulmonary functional changes. Examination of FEV,/FVC, a measure of airway obstruction, from the medical records for 30 workers with 10 or more years of caprolactam exposure (average of 3.7 to 9.9 mg/m 3 , with shorter duration exposures ranging up to 35 mg/m 3 ) did not show evidence of respiratory health effects related to working in areas with caprolactam exposure (Billmaier, 1992) .
One other study (Patel, 1990) involving the analysis of the spirometric lung functions of 173 workers engaged in various sections of a caprolactam plant for a mean of 12 years showed no difference in worker's lung functions when compared with healthy nonexposed volunteers. However, atmospheric concentrations of caprolactam to which the workers had been exposed were not measured or provided, thereby rendering this study of limited use.
This study was conducted to assess the potential subchronic inhalation toxicity of caprolactam when administered as an aqueous aerosol to rats via whole-body exposure and was enhanced with the inclusion of motor activity measurements and a functional observational battery to assess any neurotoxic potential of caprolactam.
METHODS
Animals. Male and female (nulliparous and nonpregnant) Sprague-Dawley-denved (CD) [CRL:CD BR] rats (Charles River Laboratories, Kingston, NY) were used. Rats were approximately 6 weeks of age at study initiation after being acclimated for 2 weeks in the laboratory. Animals were housed two per cage in suspended stainless-steel wire-mesh cages during the initial acclimation week and, thereafter, were housed individually during all nonexposurc periods. Environmental conditions for animal husbandry were maintained with a 12-h light/dark cycle (fluorescent light), a temperature of 20-27°C, and a relative humidity of 21-74%. Food (Certified Rodent Diet, No. 5002, Meal, PM1 Feeds, Inc., St. Louis, MO) and water were available ad libitum during nonexposure periods. All animals considered suitable for the study on the basis of good physical condition during pretest physical examinations, ophthalmology, and body weight data were randomly assigned to control or treated groups to equalize mean group weights. Individual weights of animals placed on test were within 20% of the mean weight for each sex.
Chemical
Caprolactam, a white, crystalline solid (purity 99.9%), was obtained from AlliedSignal, Inc. (Hopewell, VA) and stored at room temperature.
Rat exposure levels and conditions. Twenty rats per sex per group were exposed to desired caprolactam concentrations of 0 (air control, Group I), 25 mg/m 3 (Group U"), 75 mg/m 3 (Group III), or 250 mg/m 3 (Group IV) for 6 h per day, 5 days per week, for 13 weeks (except during functional observation battery testing). After the last caprolactam exposure, 10 animals/sex/group entered a 4-week recovery period. On each treatment day, rats within a particular treatment group were placed in stainless-steel wire-mesh cages suspended in a 1000-liter stainless-steel and glass exposure chamber (Wahmann Mfg. Co., Timonium, MD). The placement of the animal in the wholebody exposure chamber was rotated at each exposure to ensure uniform exposure of the animals.
Atmosphere generation and analyses. Prior to initiation of the present study, a study (results not shown) was designed and conducted to assess the feasibility of generating an aerosol atmosphere of caprolactam. Chamber trials were initiated to compare two different methods: (1) aerosolization from an aqueous test material solution (1:1), and (2) sublimation/evaporation by heating the test material. The results clearly indicated diat the aerosolization method was far superior for achieving high atmospheric levels of caprolactam for extended periods and was selected to be used for the present 13-week inhalation toxicity study on caprolactam. Whole-body exposure was selected as being less stressful than nose-only exposure. The test material was introduced into the chamber air supply as an aerosol. A 1:1 solution, prepared by dissolving caprolactam in an equal amount, by weight, of distilled, demineralized water, was placed in a 250-ml Erlenmeyer flask and continuously stirred on a stirplate. The solution was fed directly, via an FMI Fluid Metering Pump, into the fluid inlet of a Spraying System. Inc. air atomizing nozzle (JCO-SS with a 1A spray setup). The aerosol so generated was mixed with incoming house air by turbulence. Conditioned house air was metered into the control chamber.
During each exposure, chamber concentration determinations were performed six times daily using gravimetric sampling. Chamber air samples for determination of the caprolactam exposure levels were withdrawn at a rate of 20 liters per minute (Lpm) for 15, 15, 5, or 2 min (Groups I, n, HI, and IV, respectively) from the breathing zone in the exposure chambers through glass-fiber filters mounted open-faced in a filter holder. A flowmeter with a metering valve, a timer, and an air pump were used to pull the samples from the sampling port. The filter papers were weighed before and after sample collection, and the gravimetric concentration (in mg/m 3 ) was calculated by dividing the weight difference in milligrams (after overnight desiccation) by the volume of air sampled in cubic meters. Samples to confirm uniform distribution of the atmosphere within the chamber were taken prior to the exposures from various sampling ports.
In addition, for each daily exposure group, one sample was also analyzed by high-pressure liquid chromatography (HPLQ using a Hewlett-Packard 1050 LC system equipped with a Phenomenex Technopak column (C, 8 , 10 /xm, 300 X 3.9 mm) and a UV detector (Waters absorbance detector at a wavelength of 210 nm). The atmospheric concentrations of caprolactam were determined by comparing the detector response of chamber samples at a retention time of approximately 5.3 min with that of appropriately diluted standards through the use of standard curves.
Particle size distribution samples were withdrawn once during each exposure and determined using an aerodynamic particle sizer (TSI Aerodynamic Particle Sizer, Model 3300, and a Model 3302 TSI Aerosol Diluter, equipped with an IBM PS/2 Model 30 computer used to program the system settings). The particle sizer was compared with a cascade impactor during the preliminary trial study and considered acceptable for the range of concentrations Samples were drawn for 20 s at a rate of 5 Lpm. The mass median aerodynamic diameter (MMAD), geometric standard deviation (GSD), and total mass concentration (TMC) were calculated by computer.
In vivo parameters.
All rats were weighed, and the amount of food consumed by each sex per group was determined once per week throughout the study allowing for the calculation of mean individual daily food consumption values.
Cage-side examinations for mortality, general appearance, and signs of toxic or pharmacological effects were made twice daily throughout the study and at least once during each exposure.
Ophthalmoscopic evaluations were performed by a veterinarian prior to the first exposure and prior to the terminal sacrifice. Eyes were examined after instillation of tropicamide by indirect ophthalmoscopy.
Hematological and serum chemistry analyses were performed on all surviving animals at the exposure and recovery terminations. Animals were fasted overnight and blood samples were collected via the orbital sinus (retrobulbar venous plexus) under light carbon dioxide anesthesia. The hematological parameters examined included erythrocyte count and morphology, total and differential leukocyte count, platelet count, hematocrit. hemoglobin concentration, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, prothrombin time, and activated partial thromboplastin time. The serum chemistry parameters that were examined included serum alanine aminotransferase, serum aspartate aminotransferase, alkaline phosphatase, blood urea nitrogen, creatinine, fasting glucose, total serum protein, albumin, globulin (calculated as total protein -albumin = globulin), albumin/globulin ratio (calculated), total bilirubin, sodium, potassium, chloride, calcium, inorganic phosphorus, and •y-glutamyl transferase.
Functional observational battery (FOB) evaluations (Irwin, 1968; Meyer et al., 1979; Moser, 1989) were conducted on 10 animals per sex per group at the following intervals: pretest, 1 and 24 h postexposure on Day 1, Weeks 2, 3, 5, 9, and 14, and week 19 (following recovery). Animals were not exposed to the test material on the days of FOB evaluations except on Day 1. Observations were performed blind with respect to the animals' treatment and the time of testing was balanced across treatment groups.
For homecage observations, each rat was observed and scored for posture, vocalization, and palpebral closure. On removal from the cage, each animal was observed and scored for ease of removal, ease of handling, lacrimation, appearance of fur, and salivation. Open-field evaluations included observations and scoring of gait, degree of locomotion, arousal, abnormal movements including tremors or convulsions, exophthalmia, piloerection, and presence or absence of diarrhea and urination. Reflex assessments consisted of scoring of responses to approach, tail pinch, finger snap, pupillary response, and air righting reflex. Additionally, landing foot splay and fore-and hindlunb grip strengths were assessed.
Motor activity was monitored using an automated Photobeam Activity System (San Diego Instruments, Inc.). Sessions were 60 min in length; each session was divided into 12 intervals of 5-min duration. During each 5-min activity session, activity counts (photobeam breaks) were recorded at 1-min intervals. Treatment groups were counterbalanced across test times.
All animals were euthanized at study termination or at the end of the 4-week recovery period by exsanguination following carbon dioxide inhalation and were necropsied. At necropsy, the adrenals, brain, liver, lungs, kidneys, ovaries, and testes (with epididymides) were weighed and recorded and organ/ body and organ/brain weight ratios were calculated. The following tissues were also removed and preserved: adrenal glands, thoracic aorta, bone (sternum and femur with articular surface), bone marrow (sternum/femur), brain (medulla/ pons, cerebrum and cerebellum), epididymides, esophagus, eyes with optic nerve, heart, kidneys, exorbital lacrimal glands, larynx, large intestine (cecum, colon and rectum), liver, lungs with mainstem bronchi, mesenteric lymph nodes, mammary gland, muscle {Biceps femoris), nasopharyngeal tissues, sciatic nerve, ovaries, pancreas, pituitary gland, prostate gland, salivary gland (submandibular), seminal vesicles, skin, small intestine (duodenum, jejunum, and ileum), spinal chord (cervical, thoracic and lumbar), spleen, stomach, testes, thymic region, thyroid gland with parathyroid glands, trachea, urinary bladder, uterus (body/horns with cervix), Zymbal's gland, and any macroscopic lesions. All tissues were placed in 10% neutral buffered formalin (NBF) except for the eyes, which were preserved in glutaraldehyde/paraformaldehyde. The portion of the skull that contained the nasopharyngeal tissues was preserved intact in 10% NBF and decalcified in 10% formic acid. It was cut transversely into four sections according to the following schedule prior to the routine histological processing (Young, 1986) . All sections were examined for the presence of macroscopic and microscopic morphological abnormalities. Section 1 included the area between the upper incisor tooth and the incisive papilla; Section 2 included the area between the incisive papilla and the first palatal ndge; Section 3 included the area between the second palatal ridge and the first upper molar tooth; and Section 4 included the area between the first upper molar tooth and the nasopharynx; Section 4 also included the pharynx. Sections of the larynx were prepared from two sites; one was the area of the ventral diverticulum and the other was the area of the ventral seromucous glands at the base of the epiglottis. The lungs and urinary bladder were infused with 10% NBF (lungs: via gravity; bladder syringe-infused) to ensure fixation. All tissues collected from rats in control and Group IV terminal sacrifice groups and. kidney, liver, lung, trachea, nasopharyngeal tissues, and any macroscopic lesions from terminal sacrifice Groups II and IH as well as from recovery sacrifice Groups I-IV were further processed to slides, stained with hemotoxylin and eosin, and examined microscopically.
Statistical analyses. Body weight, body weight gain, food consumption, organ weights, and clinical parameters were analyzed by a one-way analysis of variance using the F distribution to assess significance. When the corresponding F test (Gill, 1978) for differences among test group means was significant, pairwise comparisons between treatment and control groups were made with Dunnett's test (Dunnett, 1955 (Dunnett, , 1964 . A statistical test for trend in the dose levels was also performed. In parametric cases (i.e., equal variance), standard regression techniques with a test for trend and lack of fit were used. In nonparametric cases, Jonckheere's test (Hollander and Wolfe, 1973) for monotonic trend was used. Bartlett's test (Snedecor and Cochran, 1967) for equal variance was conducted at the 1% risk level. All other statistical analyses were conducted at the 5 and 1%, two-sided risk level. Analysis of motor activity counts were conducted on the total number of beam breaks in the 5-min interval for each animal. The analysis was a profile analysis across all testing days and the twelve 5-min intervals nested within the testing days. The analysis tested for treatment effects, sex differences, treatment group X sex interactions, and these effects crossed with testing days and intervals. Pairwise contrasts comparing each group with control were performed when the overall group main effect was statistically significant. The residuals from the models were tested for normality by the Shapiro-Wilk W (Shapiro and Wilk, 1965) or the Kolomogorov D test (Stephens, 1974) for normality. All results were reported at the 5%, or less, level of significance. The data were transformed by Blom's inverse normal transformation (Blom, 1958) , if needed, to achieve normality of the model residuals.
RESULTS
The achieved mean (± SD) exposure concentration for each group was very close, especially with respect to the gravimetric exposure determinations, to the respective target concentration ( Table 1) .
The large standard deviation for the air control gravimetric samples was the result of a few values as high as 1.4 mg/m 3 . Some amount of variability for an air control group, by gravimetric measure, is typical and representative of collection of background dust or animal dander. The exposure group samples analyzed by HPLC compared closely to the respective gravimetric results. The differences between measured (analytical and gravimetric) and nominal concentrations were considered typical for this type of exposure and represent aerosol deposition on surfaces within the exposure chambers, as well as the dilution resulting from the 50% by weight water content. A minimal quantity of caprolactam was analytically detected on samples from die air control chamber during the first 7 weeks of the study. Although the quantities detected were below the limit of quantification (0.33 mg/m 3 ), the air control group animals were moved into a separate exposure and housing room during the eighth week for the balance of the study. Chamber temperature averaged 25°C and chamber relative humidity averaged 50%.
Particle size distribution measurements for the test material exposures (Table 2) indicated that a comparable respi- " SD is in parentheses. * Below limit of quantification.
rable particle size was attained at each exposure concentration with an average MMAD of 2.9 /xm and an average GSD of 1.7. Aerosol atmospheres with these characteristics are considered highly respirable to the rat (Mauderly et al., 1987; Raabe et al., 1988) . All animals survived to the termination of the study. During in-chamber observations, there appeared to be treatment-related increases in respiratory (labored breathing) and secretory (nasal discharge) responses during the exposure periods beginning with the second week of the study. The responses were seen at all exposure levels of caprolactam, with slight increases in incidence with increased exposure level. The responses did not completely abate during the study, although the incidence was generally reduced during the second half of the study. From weekly physical examinations and daily observations, at all levels of caprolactam exposure in both sexes during the 13 weeks of exposures, there appeared to be an exposure-related trend toward increased incidence of red staining (facial area), clear nasal discharge, and moist rales. The incidence of signs in air control animals was typical for this type of exposure regimen. All of the signs observed during the exposure period completely abated by the end of the recovery period.
Based on ophthalmological examinations, no treatment-related ocular changes were seen preceding die terminal sacrifice. There were no statistically significant differences in body weights between the air control and test material-exposed animals. However, a trend was evident throughout the exposure and recovery periods for slightly reduced weight gain in Group IV (243 mg/m 3 ) male rats compared with the Group I (air control) males (Fig. 1) .
There was no consistent evidence of a neurotoxic effect of caprolactam based on evaluations of the functional observational battery performed at proscribed intervals throughout the exposure and recovery periods. Evaluations of neuromuscular function and coordination, central nervous system activity and excitability, sensorimotor responses, and autonomic function were considered normal. Statistically significant decreases in foot landing splay measurements compared with control values were found for some female groups at several intervals throughout the study. In addition, forelimb grip strength was decreased in the midexposure (70 mg/m 3 ) group in a single trial in Week 5. These decreases were not considered toxicologically significant for several reasons: the decreases were not related to the exposure level; the decreases were not seen in both trials at various intervals throughout the study; and the values were comparable to control values from similar studies at the testing facility.
Furthermore, there was no indication of a neurotoxic effect of caprolactam based on motor activity evaluations throughout the exposure and observation periods. There were, however, statistically significant increases in motor activity in the midexposure (70 mg/m 3 ) group at Weeks 9 and 14 and in the midexposure females at recovery. Since increased motor activity values were present in the midexposure females at pretest and the increases were not seen in the high-exposure (243 mg/m 3 ) group, these increases were not considered to be of toxicological significance.
The only statistically significant difference in hematology values was a decreased hemoglobin value in Group II (24 mg/m 3 ) females at the terminal sacrifice. This was not considered treatment related since it was not seen at the higher exposure levels. There were no other statistically or toxicologically significant differences in hematology values between the control and test material-exposed animals. Moreover, the only statistically significant differences in serum chemistry values, seen at the terminal sacrifice, were decreased AST, glucose, and GGT values in Group III (70 mg/m 3 ) females and decreased ALT and GGT values in Group II (24 mg/m 3 ) females. None of these differences were considered treatment related because they were not seen at the high exposure level. Organ weight data suggested only very minor changes. The only statistically significant difference seen among organ weights was a decreased lung/terminal body weight ratio in Group HJ (70 mg/m 3 ) male rats. In the absence of any corroborative microscopic pathology findings and since the changes were seen in only one sex, none of these changes were considered clearly treatment related.
Microscopic findings related to the whole-body exposure to the test material were seen in the nasoturbinal tissues and larynx.
Findings in the nasoturbinal tissues consisted of slight to moderate hypertrophy/hyperplasia of goblet cells in the respiratory mucosa and slight to moderately severe intracytoplasmic eosinophilic material in epithelial cells of the olfactory mucosa. A minimal to slight background incidence of these findings was seen in air-exposed control animals. These findings, summarized in Table 3 , were considered by the pathologist (Dr. Henry Bolte) to be within normal limits for test animals of this age and strain at the testing facility (Huntingdon Life Sciences, Inc.). At the end of the exposure period, dose-related increases in the severity of findings were seen in male and female rats that received the two highest exposures (70 and 243 mg/m 3 ). The incidence and severity of these findings in animals exposed to the lowest concentration of caprolactam (24 mg/m 3 ) were considered comparable to those in control animals. At the end of the recovery period, dose-related increases in the severity of the nasoturbinal findings were still seen in males and females that received the 70 and 243 mg/m 3 concentrations of caprolactam for 13 weeks (Table 4) .
In the larynx, at the end of the exposure period, there was an exposure-related increase in the incidence of squamous/squamoid metaplasia/hyperplasia of the pseudostratified columnar epithelium covering the ventral seromucous gland (Table 5 ). In all of the affected rats, the metaplastic epithelium was focal, minimal to slight, and well differentiated with no apparent atypia or dysplasia. This finding was seen in all caprolactamexposed groups and was most pronounced in animals that received the highest exposure (243 mg/m 3 ); a small number of rats in this group had minimal keratinization of the metaplastic epithelium. At the end of the recovery period, a low incidence of focal squamous/squamoid metaplasia/hyperplasia, without keratinization, was seen in groups exposed to 70 and 243 mg/m 3 caprolactam. The minimal metaplastic change was less severe than the change seen at the end of the exposure period.
Other microscopic findings in the nasoturbina) tissues and in the larynx and in other tissues and organs examined occurred with comparable incidence and severity in rats from the control and exposure groups. These incidental findings, seen in rats of this strain and age, were not considered related to the wholebody exposure to caprolactam for 13 weeks.
DISCUSSION
The present study was conducted to determine the subchronic toxicity from inhalation exposure to caprolactam in rats. An additional objective was to assess the potential neurotoxicity of caprolactam. Repeated exposure of rats to gravimetrically determined aerosol concentrations of 24 (±5.6), 70 (±18), and 243 (±36) mg/m 3 for 6 h per day, 5 days per week, for 13 weeks, followed by a 4-week recovery, resulted in no mortality and no adverse treatment-related effects as evidenced by ophthalmoscopic examinations, body weight and food consumption measurements, neurobehavioral evaluations, clinical pathology (hematology and serum chemistry) evaluations, organ weight measurements, or macroscopic pathology exami- nations during the exposure and recovery periods. There was no evidence suggestive of any systemic toxicity. Two microscopic findings observed in the nasoturbinal tissues that were considered to be related to inhalation exposure to caprolactam were minimal to moderate hypertrophy/hyperplasia of goblet cells in the respiratory mucosa and minimal to moderately severe intracytoplasmic eosinophilic material in epithelial cells of the olfactory mucosa.
The increased severity of hypertrophy/hyperplasia of goblet cells seen in the respiratory mucosa of the nasal septum, which was most pronounced in the anterior region of the nasal turbinates (Level 1), was considered to be a localized adaptive response to the minimal irritant effect commonly associated with paniculate compounds rather than an adverse toxicological response to the test material in the nasal passages. Similar responses have been seen in rats exposed to aerosols of mild irritants in other studies conducted at this facility (Huntingdon Life Sciences, Inc.). Adaptation as a response to a tissue insult has been further mentioned and described in the literature (Barrow, 1986; Haschek and Rousseaux, 1991) . In addition, a dose-related increase in severity of intracytoplasmic eosinophilic material in the epithelial cells of the olfactory mucosa, as seen in this study, has been observed in rats from other subchronic inhalation studies of mild irritants conducted in this facility. The exact nature of this commonly seen material, presumed to be secretory, and reasons for its increase following exposure to a variety of test materials are uncertain but presumably represent a nonspecific response to the inhalation of the test material (Monticello et al, 1990) . In the laryngeal tissues, a minimal exposure-related increase in the incidence of minimal squamous/squamoid metaplasia/ hyperplasia of the pseudostratified columnar epithelium covering the ventral seromucous gland was seen at both the terminal and recovery sacrifice. However, at the recovery sacrifice, reversal of this adaptive effect (Lewis, 1991) was complete for most of the animals from the treatment groups and showed evidence of some recovery in the remaining animals (see Table 5 ). Keratinization of the laryngeal epithelium, considered to be an adverse effect, had completely resolved by the end of the recovery period.
Stratified squamous epithelium normally lines the upper portion of the larynx, whereas the remainder is lined by pseudostratified columnar (ciliated/nonciliated) epithelium. The pseudostratified columnar epithelium on the ventral floor of the larynx at the base of the epiglottis, cranial to the ventral diverticulum and overlying the seromucous glands, is especially sensitive to inhaled materials. Therefore, this site is to be considered a target for histopathological evaluations following inhalation exposure to vapors and aerosols (Sagartz et al, 1992) . Squamous/squamoid metaplasia of the pseudostratified columnar epithelium, as seen in this study, was considered to be an adaptive response to the inhalation of caprolactam due to its mild irritant effect on the highly sensitive epithelium covering the ventral floor of the larynx.
CONCLUSION
Whole-body exposure of Sprague-Dawley rats to caprolactam as a liquid aerosol for 6 h/day, 5 days/week, for 13 weeks at gravimetrically determined levels of 24, 70, and 243 mg/m 3 resulted in transient clinical signs (secretory and respiratory) as well as adaptive respiratory tract effects (microscopically detected nasoturbinal changes) at all exposure levels and adverse respiratory tract effects (microscopically detected laryngeal changes) at the highest exposure level.
The laryngeal keratinization seen at 243 mg/m 3 is the only finding considered to be a possible adverse effect, with other findings at lower levels simply a normal response to inhaled foreign paniculate material. Therefore, under the conditions of this study, the no-observed-adverse-effect level (NOAEL) for caprolactam in Sprague-Dawley rats was considered to be 70 mg/m 3 for the upper respiratory tract. In addition, from the results obtained in this study, the no-observed-effect level (NOEL) for caprolactam in rats was considered to be 243 mg/m 3 for the lower respiratory tract, for systemic toxicity, and for neurotoxicity.
The results reported in the present study and the background information provided in the introduction section, describing occupational studies of exposure to caprolactam, support the current ACGIH TLV-TWA of 5 ppm, or 23 mg/m 3 , as appropriate for caprolactam. Deleterious effects including irritation, neurotoxicity, or any other systemic effect would not be anticipated nor have any such effects ever been reported to occur from inhalation exposures to caprolactam at or below the current TLV.
